vs
如新（NUS）与Wellgistics Health, Inc.（WGRX）财务数据对比。点击上方公司名可切换其他公司
如新的季度营收约是Wellgistics Health, Inc.的221.7倍（$370.3M vs $1.7M）。如新净利率更高（3.9% vs -1667.2%，领先1671.1%）
如新企业集团是一家美国多层次直销企业，主打研发并销售个人护理产品与营养膳食补充产品，旗下拥有Nu Skin及Pharmanex两大品牌，目前已在全球54个市场开展业务，依托约120万独立销售代表的销售网络覆盖全球市场。
Wellgistics Health, Inc.是一家总部位于美国的医疗服务企业，主营处方药物、非处方药品及医疗用品的分销业务，服务对象包括零售药房、长期护理机构及各类独立医疗服务提供者。
NUS vs WGRX — 直观对比
营收规模更大
NUS
是对方的221.7倍
$1.7M
净利率更高
NUS
高出1671.1%
-1667.2%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $370.3M | $1.7M |
| 净利润 | $14.5M | $-27.9M |
| 毛利率 | 70.7% | -470.2% |
| 营业利润率 | 6.3% | -1517.5% |
| 净利率 | 3.9% | -1667.2% |
| 营收同比 | -16.9% | — |
| 净利润同比 | 140.1% | — |
| 每股收益（稀释后） | $0.27 | $-0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NUSWGRX
| Q4 25 | $370.3M | $1.7M | ||
| Q3 25 | $364.2M | $3.0M | ||
| Q2 25 | $386.1M | $7.8M | ||
| Q1 25 | $364.5M | $10.9M | ||
| Q4 24 | $445.6M | — | ||
| Q3 24 | $430.1M | — | ||
| Q2 24 | $439.1M | — | ||
| Q1 24 | $417.3M | — |
净利润NUSWGRX
| Q4 25 | $14.5M | $-27.9M | ||
| Q3 25 | $17.1M | $-34.3M | ||
| Q2 25 | $21.1M | $-6.7M | ||
| Q1 25 | $107.5M | $-32.4M | ||
| Q4 24 | $-36.1M | — | ||
| Q3 24 | $8.3M | — | ||
| Q2 24 | $-118.3M | — | ||
| Q1 24 | $-533.0K | — |
毛利率NUSWGRX
| Q4 25 | 70.7% | -470.2% | ||
| Q3 25 | 70.5% | 7.7% | ||
| Q2 25 | 68.8% | 6.5% | ||
| Q1 25 | 67.8% | 6.4% | ||
| Q4 24 | 62.7% | — | ||
| Q3 24 | 70.1% | — | ||
| Q2 24 | 70.0% | — | ||
| Q1 24 | 70.5% | — |
营业利润率NUSWGRX
| Q4 25 | 6.3% | -1517.5% | ||
| Q3 25 | 5.9% | -1047.1% | ||
| Q2 25 | 8.0% | -70.6% | ||
| Q1 25 | -2.7% | -288.6% | ||
| Q4 24 | -11.9% | — | ||
| Q3 24 | 4.2% | — | ||
| Q2 24 | -28.6% | — | ||
| Q1 24 | 2.1% | — |
净利率NUSWGRX
| Q4 25 | 3.9% | -1667.2% | ||
| Q3 25 | 4.7% | -1139.0% | ||
| Q2 25 | 5.5% | -85.6% | ||
| Q1 25 | 29.5% | -298.5% | ||
| Q4 24 | -8.1% | — | ||
| Q3 24 | 1.9% | — | ||
| Q2 24 | -26.9% | — | ||
| Q1 24 | -0.1% | — |
每股收益（稀释后）NUSWGRX
| Q4 25 | $0.27 | $-0.24 | ||
| Q3 25 | $0.34 | $-0.46 | ||
| Q2 25 | $0.43 | $-0.11 | ||
| Q1 25 | $2.14 | $-0.62 | ||
| Q4 24 | $-0.73 | — | ||
| Q3 24 | $0.17 | — | ||
| Q2 24 | $-2.38 | — | ||
| Q1 24 | $-0.01 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $239.8M | $42.6K |
| 总债务越低越好 | — | $23.5M |
| 股东权益账面价值 | $805.2M | $-12.4M |
| 总资产 | $1.4B | $30.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NUSWGRX
| Q4 25 | $239.8M | $42.6K | ||
| Q3 25 | $253.0M | $4.2M | ||
| Q2 25 | $265.4M | $419.9K | ||
| Q1 25 | $213.6M | $2.5M | ||
| Q4 24 | $198.0M | — | ||
| Q3 24 | $237.8M | — | ||
| Q2 24 | $232.9M | — | ||
| Q1 24 | $221.2M | — |
总债务NUSWGRX
| Q4 25 | — | $23.5M | ||
| Q3 25 | — | $24.8M | ||
| Q2 25 | — | $23.3M | ||
| Q1 25 | — | $24.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益NUSWGRX
| Q4 25 | $805.2M | $-12.4M | ||
| Q3 25 | $799.8M | $6.8M | ||
| Q2 25 | $787.8M | $905.3K | ||
| Q1 25 | $754.0M | $4.5M | ||
| Q4 24 | $651.5M | — | ||
| Q3 24 | $706.9M | — | ||
| Q2 24 | $686.2M | — | ||
| Q1 24 | $810.2M | — |
总资产NUSWGRX
| Q4 25 | $1.4B | $30.5M | ||
| Q3 25 | $1.4B | $52.8M | ||
| Q2 25 | $1.4B | $54.2M | ||
| Q1 25 | $1.4B | $58.1M | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.6B | — | ||
| Q1 24 | $1.7B | — |
负债/权益比NUSWGRX
| Q4 25 | — | — | ||
| Q3 25 | — | 3.66× | ||
| Q2 25 | — | 25.72× | ||
| Q1 25 | — | 5.39× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $16.6M | $-6.3M |
| 自由现金流经营现金流 - 资本支出 | $5.9M | — |
| 自由现金流率自由现金流/营收 | 1.6% | — |
| 资本支出强度资本支出/营收 | 2.9% | — |
| 现金转化率经营现金流/净利润 | 1.15× | — |
| 过去12个月自由现金流最近4个季度 | $46.0M | — |
8季度趋势，按日历期对齐
经营现金流NUSWGRX
| Q4 25 | $16.6M | $-6.3M | ||
| Q3 25 | $27.5M | $-1.1M | ||
| Q2 25 | $35.8M | $-2.1M | ||
| Q1 25 | $389.0K | $-1.3M | ||
| Q4 24 | $25.8M | — | ||
| Q3 24 | $31.4M | — | ||
| Q2 24 | $51.2M | — | ||
| Q1 24 | $3.3M | — |
自由现金流NUSWGRX
| Q4 25 | $5.9M | — | ||
| Q3 25 | $17.6M | — | ||
| Q2 25 | $35.8M | — | ||
| Q1 25 | $-13.2M | — | ||
| Q4 24 | $13.2M | — | ||
| Q3 24 | $22.8M | — | ||
| Q2 24 | $43.1M | — | ||
| Q1 24 | $-9.0M | — |
自由现金流率NUSWGRX
| Q4 25 | 1.6% | — | ||
| Q3 25 | 4.8% | — | ||
| Q2 25 | 9.3% | — | ||
| Q1 25 | -3.6% | — | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | 5.3% | — | ||
| Q2 24 | 9.8% | — | ||
| Q1 24 | -2.1% | — |
资本支出强度NUSWGRX
| Q4 25 | 2.9% | — | ||
| Q3 25 | 2.7% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 3.7% | — | ||
| Q4 24 | 2.8% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 1.9% | — | ||
| Q1 24 | 2.9% | — |
现金转化率NUSWGRX
| Q4 25 | 1.15× | — | ||
| Q3 25 | 1.61× | — | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.79× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NUS
| Other | $161.9M | 44% |
| Mainland China Segment | $52.0M | 14% |
| Southeast Asia Pacific Segment | $50.5M | 14% |
| Europe And Africa Segment | $41.8M | 11% |
| Hong Kong Taiwan Segment | $29.6M | 8% |
| South Korea Segment | $28.4M | 8% |
| Rhyz Other Segment | $6.1M | 2% |
WGRX
暂无分部数据
